Control group:6 months of routine regimen

2 trials

Sponsors

National Center for TB Control and Prevention, China CDC

Conditions

Tuberculosis

Phase 4

IMMUINOTHERAPY INTERVENTION STUDY IN PATIENTS WITH UNTREATED SMEAR NEGATIVE PULMONARY TUBERCULOSIS

Active, not recruitingChiCTR-TRC-14005160

National Center for TB Control and Prevention, China CDCTuberculosis

Start: 2014-10-01Updated: 2017-04-18

Study for a new therapy of shortening the treatment course of patients with smear negative pulmonary tuberculosis by immune intervention

RecruitingChiCTR1900023398

National Center for TB Control and Prevention, China CDCTuberculosis

Start: 2019-06-10Updated: 2019-05-27